MENU PIPELINE Developing life more humann We’re focused on creating the cutting-edge therapies and technologies that can change life for the better. Our Technosphere® Technology can be applied to a number of therapeutic areas that are both in high demand for innovation, and in need for a different kind of treatment option for people living with these conditions. Our pipeline reflects how we, as well as our partners, are applying our technology to develop and advance new products to not only help people take control of their health, but truly thrive. explore our pipeline and collaborations Afrezza® (insulin human) Inhalation Powder USA, Brazil (with Biomm) approved Afrezza® (insulin human) Inhalation Powder International Expansion: India (Cipla) phase3 Pediatric Afrezza® (insulin human) Inhalation Powder Indication Expansion phase3 Tyvaso DPI™ (collaboration with United Therapeutics) phase3 MNKD-101 pre-ind MNKD-201 formulation MNKD-301 formulation MNKD-701 formulation Cannabidiol Technosphere® (licensed to Receptor Life Sciences, milestones and royalty payments) pre-ind Small molecule enzyme inhibitor (sold to Fosun Pharma in 2017, MNKD eligible for royalty payments) phase1 Learn more about partnering with us. Together, we can create a world without limit for all. partner with us Explore our published research. See how our technologies and therapies can help more people take control of their health. view publications Make a humann connection with us. Reach out anytime. MannKind Corporation 30930 Russell Ranch Road, Suite 300 Westlake Village, CA 91362 USA contact@mannkindcorp.com 818.661.5000 sign up for email updates Terms of Use Privacy Policy Patent Notices Corporate Governance ©2021 MannKind Corporation. All rights reserved.